EUVIMED · CrossrefZeitschrift
NAM Journal
ISSN 3050-6204 · Elsevier BV
Neueste Artikel
Promoting co-creation and flexibility in transdisciplinary research projects on alternatives - the agile approach of the Virtual Human Platform for Safety Assessment project
Decarbonizing Preclinical Research: Sustainability Benefits of Caenorhabditis elegans as a Non-Animal Alternative to Rodent Testing
Enabling NAMs-based bioaccumulation assessment: EPAA recommendations in support of the EU “Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments"
Implementation of NAMs for Endocrine Disruptors Through Collective Action
Investigations into the biological activity of avobenzone as part of a Next Generation Risk Assessment
A case study with benzoic acid demonstrating how integration of In Silico Tools, mechanistic In Vitro NAM, and toxicological data improves definition of point of departure for a chemically defined class in read-across assessments
3Rs at the European Medicines Agency: Past and future activities
MicroRNA network regulation of developmental bone toxicity in a human embryonic stem cell osteogenic model
Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure
A human tracheobronchial epithelial tissue airway injury and remodeling (hTET-AIR) NAM for assessing epithelial pathology: From goblet cell hyperplasia to squamous metaplasia
Microfluidics-based multi-endpoint assessment of reproductive toxicity in C. elegans in response to heavy metal exposure
Development of machine learning models to predict chemical-induced ocular irritation
REACH revision: if not now, what can we do for modernising chemical safety assessment?
New frontiers in anti-cancer drug testing: The need for a relevant In vitro testing model
Exploring animal methods bias in biomedical research funding: Workshop proceedings and action steps
Development of in silico models that define the applicability domains of binary classifiers: An ITSv2-defined approach for identifying skin sensitization hazards
A systematic approach towards long-term, serum-free cultivation of fish cells with the RTgill-W1 cell line as example
Highlighting best practices to advance next-generation risk assessment of cosmetic ingredients
Complement-ARIE: Catalyzing the development and adoption of new approach methodologies
Botulinum neurotoxin: Tracking the transition from lethal dose to in vitro models
A survey to evaluate animal methods bias experienced by India-based researchers in the peer review of manuscripts and grant applications
Qualitative and quantitative evaluation of Fetal Bovine Serum composition: toward ethical and best quality in vitro science
Pursuing societal impact in research projects on NAM development: An analysis of routes to impact
Next-generation non-animal models for inflammatory bowel disease: In vitro and in silico approaches for mechanistic understanding
Comparative study of (Q)SAR models for predicting the environmental fate of cosmetic ingredients: Persistence, bioaccumulation, and mobility
New approach methodologies for evaluating developmental and reproductive toxicity potential: Review on state of the art, applicability for cosmetic related ingredients and coverage of developmental stages
Transitional initiatives for advancing the phasing out of the use of animals for drug and chemical safety testing: The IHI VICT3R project for reducing the use of animals by implementing virtual control groups
Towards replacement of animal experimentation in scientific research and regulatory testing: launch of NAM Journal
Advice for bad toxicologists
GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based tools
EUVIMED